Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy

医学 肝硬化 内科学 胃肠病学 重症监护医学
作者
Alberto Muñoz,Florencia Pollarsky,Mónica Marino,Mariano Cartier,Horacio Vázquez,Pablo Salgado,Gustavo Adolfo Sierra Romero
出处
期刊:World Journal of Gastroenterology [Baishideng Publishing Group]
卷期号:27 (28): 4639-4652 被引量:18
标识
DOI:10.3748/wjg.v27.i28.4639
摘要

This review summarizes the safety and efficacy of statins in patients with cirrhosis. Due to concerns about the safety of statins in patients with impaired liver function, they have recently been investigated as a potential treatment option in cirrhosis. The most clinically significant adverse event is statin-related myopathy, and this may be related to the high serum statin concentrations in the setting of severely impaired liver function. Rhabdomyolysis is the most serious and potentially life-threatening manifestation. It has recently been demonstrated that the recommended dose of simvastatin in patients with decompensated cirrhosis would be 20 mg/d because higher values, such as 40 mg/d, are associated with many adverse events, especially muscle injury. Likewise, simvastatin should not be administered to patients with Model for End-stage Liver Disease score > 12 and/or Child-Pugh class C because of the high risk of severe muscle injury. Due to the pleiotropic effects, the focus on statins has shifted from being considered harmful to something useful. Through these effects, statins could prevent liver-related morbidity and mortality in cirrhotic patients. Observational studies in large populations of patients with cirrhosis have shown that treatment with statins to decrease high cholesterol levels was associated with a reduced risk of hepatic decompensation, hepatocellular carcinoma development and death. The few randomized controlled trials in patients with cirrhosis and portal hypertension showed that statins lower portal pressure, quite likely through a reduction in hepatic resistance. Another large randomized controlled trial in patients with variceal bleeding showed that simvastatin in addition to standard of care did not prevent rebleeding but improved survival rate. Despite these encouraging outcomes, the quality of the evidence regarding the use of statins is low or very low due to the observational characteristics of most of the studies involved. Therefore, it is advisable to perform further randomized controlled trials on a large series of patients with hard clinical endpoints, using different statin types and varying doses. The objectives would be to prevent liver-related morbidity and mortality rather than treating cirrhosis complications to take additional information that makes it possible to add statins to the standard of care of these patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
HXX关闭了HXX文献求助
2秒前
小笼包完成签到,获得积分10
2秒前
3秒前
4秒前
5秒前
平淡雪枫完成签到 ,获得积分10
7秒前
沙猛完成签到,获得积分10
8秒前
ss2255完成签到,获得积分10
8秒前
8秒前
万能图书馆应助查丽采纳,获得10
9秒前
ww发布了新的文献求助10
10秒前
BlingBling发布了新的文献求助10
10秒前
JamesPei应助Fluncise采纳,获得10
12秒前
bkagyin应助Abby采纳,获得10
15秒前
16秒前
和谐蛋蛋发布了新的文献求助10
16秒前
orixero应助ye采纳,获得10
22秒前
HJY发布了新的文献求助20
24秒前
wyx完成签到 ,获得积分10
27秒前
Hello应助王三采纳,获得10
28秒前
扶休应助卡卡采纳,获得200
28秒前
小晚发布了新的文献求助10
29秒前
30秒前
30秒前
30秒前
31秒前
31秒前
ye完成签到,获得积分10
31秒前
冷傲威发布了新的文献求助10
33秒前
查丽发布了新的文献求助10
33秒前
Andrea0899发布了新的文献求助20
33秒前
lalalahei完成签到,获得积分20
33秒前
Abby发布了新的文献求助10
34秒前
34秒前
明亮的代荷完成签到,获得积分10
35秒前
lalalahei发布了新的文献求助10
36秒前
surxwy发布了新的文献求助10
37秒前
prime完成签到,获得积分10
37秒前
Hello应助热木采纳,获得10
37秒前
高分求助中
Algorithmic Mathematics in Machine Learning 500
Handbook of Innovations in Political Psychology 400
Mapping the Stars: Celebrity, Metonymy, and the Networked Politics of Identity 400
引进保护装置的分析评价八七年国外进口线路等保护运行情况介绍 300
《続天台宗全書・史伝1 天台大師伝注釈類》 300
Visceral obesity is associated with clinical and inflammatory features of asthma: A prospective cohort study 300
Getting Published in SSCI Journals: 200+ Questions and Answers for Absolute Beginners 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3839912
求助须知:如何正确求助?哪些是违规求助? 3382151
关于积分的说明 10521568
捐赠科研通 3101604
什么是DOI,文献DOI怎么找? 1708153
邀请新用户注册赠送积分活动 822237
科研通“疑难数据库(出版商)”最低求助积分说明 773223